3Legs Resources plc Stock London S.E.
Equities
IM00B52P5P72
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
2019 | SalvaRx Evaluates Takeover Opportunities | CI |
2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
Financials (USD)
Sales 2017 | - | Sales 2018 | - | Capitalization | 28.53M |
---|---|---|---|---|---|
Net income 2017 | -1M | Net income 2018 | - | EV / Sales 2017 | - |
Net Debt 2017 | 2.22M | Net Debt 2018 | 763K | EV / Sales 2018 | - |
P/E ratio 2017 |
-4.13
x | P/E ratio 2018 |
83
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 20.33% |
Managers | Title | Age | Since |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 19-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
CHM | Chairman | 68 | - |
Peter Redmond
BRD | Director/Board Member | 76 | - |
Gregory Bailey
FOU | Founder | 68 | 06-12-31 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |